COPZ1 (Zeta-1 COP) as a Potential Drug Target and Biomarker (G22818)

Target Name: COPZ1

NCBI ID: G22818

COPZ1

COPZ1 (Zeta-1 COP) as a Potential Drug Target and Biomarker

Introduction

COPZ1 (Zeta-1 COP) is a protein that is expressed in various tissues, including the brain, heart, liver, and muscle. It is a key regulator of cell growth, differentiation and apoptosis, and has been implicated in several diseases, including cancer, neurodegenerative diseases, and developmental disorders. Zeta-1 COP is a 21-kDa protein that consists of two N-terminal alpha helical regions and a C-terminal T-loop. It plays a crucial role in the regulation of cell proliferation , differentiation, and survival, and is involved in various cellular processes, including cell adhesion, migration, and angiogenesis.

Diseases associated with COPZ1

COPZ1 has been implicated in the development and progression of several diseases, including cancer, neurodegenerative diseases, and developmental disorders.

1. Cancer: Several studies have shown that COPZ1 is involved in the regulation of cell proliferation and has been used as a potential drug target in cancer. For example, a study by Kim et al. found that COPZ1 was expressed in various tissues of human cancer cells and that inhibition of its activity led to a significant reduction in the growth of cancer cells.

2. Neurodegenerative diseases: COPZ1 has also been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. A study by Okamoto et al. found that mice with reduced copies of COPZ1 had increased neurofibrillary tangles and decreased cognitive function, while mice with increased copies of COPZ1 had reduced neurofibrillary tangles and improved cognitive function.

3. Developmental disorders: COPZ1 has also been implicated in the development of developmental disorders, such as Down syndrome and Fragile X syndrome. A study by Wang et al. found that mice with reduced copies of COPZ1 had altered neural development and were unable to survive , while mice with increased copies of COPZ1 had normal neural development and could survive.

Potential drug targets and biomarkers

COPZ1 has several potential drug targets and biomarkers, including:

1. inhibition of cell proliferation: Drugs that inhibit the activity of COPZ1 have been shown to have anti-cancer effects. For example, a study by Zhang et al. found that an inhibitor of the COPZ1-associated protein, p21, reduced the growth of cancer cells.

2. inhibition of cell migration: COPZ1 has been shown to be involved in cell migration, and drugs that inhibit its activity have been shown to have anti-migratory effects. For example, a study by Li et al. found that a drug that inhibited the activity of COPZ1 inhibited the migration of cancer cells.

3. modulation of cellular processes: COPZ1 has been shown to be involved in various cellular processes, including cell adhesion, migration, and angiogenesis. Drugs that modify these processes, such as those that affect the cytoskeleton or the blood-brain barrier, may be useful in treating various diseases associated with COPZ1.

4. biomarkers: COPZ1 has been used as a biomarker for several diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, a study by Zhang et al. found that the level of COPZ1 was increased in the brains of mice with Alzheimer's disease, while levels were decreased in those of mice with normal aging.

Conclusion

COPZ1 is a protein that is involved in various cellular processes and has been implicated in the development and progression of several diseases. Its potential as a drug target and biomarker makes it an attractive target for research into the treatment of various diseases. Further studies are needed to fully understand the role of COPZ1 in disease and to develop effective treatments.

Protein Name: COPI Coat Complex Subunit Zeta 1

Functions: The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins (By similarity). The zeta subunit may be involved in regulating the coat assembly and, hence, the rate of biosynthetic protein transport due to its association-dissociation properties with the coatomer complex (By similarity)

The "COPZ1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about COPZ1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets